The impact of stability and solubility of photodynamic therapies on method development

A well characterised and fully validated bioanalytical method used for measuring a novel porphyrin photodynamic therapy (CompoundI) in human plasma was modified in order to enable the measurement of a structurally and metabolically related compound (CompoundII) in rat plasma.